Flow cytometric detection of platelet-reactive antibodies and application in platelet crossmatching

Transfusion

Volumn 36, Issue 3, 1996, Pages 250-255

  Kohler M ^a   Dittmann, J ^b   Legler, T J ^b   Lynen, R ^b   Humpe, A ^b   Riggert, J ^b   Neumeyer, H ^b   Pies, A ^b   Panzer, S ^c   Mayr, W R ^c  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Department of Child and Adolescent Psychiatry and Psychotherapy   (Germany)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; MONOCLONAL ANTIBODY; THROMBOCYTE ANTIBODY;

ALLOIMMUNIZATION; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; RELIABILITY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 9244243041     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36396182144.x     Document Type: Article

References (31)

1. Slichter SJ. Platelet transfusions: a constantly evolving therapy. Thromb Haemost 1991;66:178-88.
2. McFarland JG, Anderson AJ, Slichter SJ. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates. Br J Haematol 1989;73:380-6.
3. Friedberg RC, Donnelly SF, Boyd JC, et al. Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization. Blood 1993;81:3428-34.
4. Murphy MF, Metcalfe P, Ord J, et al. Disappearance of HLA and platelet-specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions. Br J Haematol 1987;67:255-60.
5. Brand A, Claas FH, Voogt PJ, et al. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions. Vox Sang 1988;54:160-6
6. McGrath K, Wolf M, Bishop J, et al. Transient platelet and HLA antibody formation in multitransfused patients with malignancy. Br J Haematol 1988;68:345-50.
7. Moroff G, Garratty G, Heal JM, et al. Selection of platelets for refractory patients by HLA matching and prospective crossmatching. Transfusion 1992;32:633-40
8. Von dem Borne AE, Ouwehand WH, Kuijpers RW. Theoretic and practical aspects of platelet crossmatching. Transfus Med Rev 1990;4:265-78.
9. Freedman J, Hornstein A. Simple method for differentiating between HLA and platelet-specific antibodies by flow cytometry. Am J Hematol 1991;38:314-20.
10. Mittal KK, Mickey MR, Singal DP, Terasaki PI. Serotyping for homotransplantation. XVIII. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 1968;6:913-27.
11. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet reactive antibodies. Blood 1987;70:1722-6.
12. Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnoses. New York: John Wiley & Sons, 1975.
13. McFarland JG, Aster RH. Evaluation of four methods for platelet compatibility testing. Blood 1987;69:1425-30.
14. Von dem Borne AE, Verbeugt FW, Oosterhof F, et al. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol 1978;39:195-207.
15. Lazarchick J, Hall SA Platelet-associated IgG assay using flow cytometric analysis. J Immunol Methods 1986;87:257-65.
16. Rosenfeld CS, Bodensteiner DC. Detection of platelet alloantibodies by flow cytometry. Characterization and clinical significance. Am J Clin Pathol 1986;85:207-12.
17. Rosenfeld CS, Nichols G, Bodensteiner DC. Flow cytometric measurement of antiplatelet antibodies. Am J Clin Pathol 1987;87:518-22.
18. Allen DL, Chapman J, Phillips PK, Ouwehand WH. Sensitivity of the platelet immunofluorescence test (PIFT) and the MAIPA assay for the detection of platelet-reactive alloantibodies: a report on two U.K. National Platelet Workshop exercises. Transfus Med 1994;4:157-64.
19. McGrath K, Holdsworth R, Veale M, et al. Detection of HLA antibodies by platelet crossmatching techniques. Transfusion 1988;28:214-6.
20. Lee PP, Garovoy MR. Flow cytometry crossmatching: the first 10 years. Transplant Rev 1994;8:1-14.
21. Worfolk LA, MacPherson BR. The detection of platelet alloantibodies by flow cytometry. Transfusion 1991;31:340-4.
22. Schiffer CA, O'Connell B, Lee EJ. Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets. Blood 1989;74:1172-6.
23. Wu KK, Hoak JC, Koepke JA, Thompson JS. Selection of compatible platelet donors: a prospective evaluation of three crossmatching techniques. Transfusion 1977;17 638-43.
24. Tosato G, Appelbaum FR, Trapani RJ, et al. Use of in vitro assays in selection of compatible platelet donors. Transfusion 1980;20:47-54.
25. Myers TJ, Kim BK, Steiner M, Baldini MG. Selection of donor platelets for alloimmunized patients using a platelet-associated IgG assay. Blood 1981;58:444-50.
26. Kakaiya RM, Gudino MD, Miller WV, et al. Four crossmatch methods to select platelet donors. Transfusion 1984;24:35-41.
27. Freedman J, Garvey MB, Salomon de Friedberg Z, et al. Random donor platelet crossmatching: comparison of four platelet antibody detection methods. Am J Hematol 1988;28:1-7.
28. Gates K, MacPherson BR. Retrospective evaluation of flow cytometry as a platelet crossmatching procedure. Cytometry 1994;18:123-8.
29. Neumüller J, Tohidast-Akrad M, Fischer M, Mayr WR. Influence of chloroquine or acid treatment of human platelets on the antigenicity of HLA and the "thrombocyte-specific" glycoproteins Ia/IIa, IIb, and IIb/IIIa. Vox Sang 1993;65:223-31.
30. Freedman J, Gafni A, Garvey MB, Blanchette V. A cost-effectiveness evaluation of platelet crossmatchmg and HLA matching in the management of alloimmunized thrombocytopenic patients. Transfusion 1989;29:201-7.
31. Garratty G, Arndt P. Applications of flow cytofluorometry to transfusion science. Transfusion 1995;35:157-78.